Non-Pharmacological and Pharmacological Treatments for Non-Acute Lumbar Disc Herniation: A Protocol for a Multicenter Pragmatic Trial.
Doori Kim, Yoon Jae Lee, Changsop Yang...
https://pubmed.ncbi.nlm.nih.gov/41477591/Actively Recruiting
Led by Jaseng Medical Foundation · Updated on 2026-09-21
200
Participants Needed
4
Research Sites
N/A
Total Duration
Researchers are comparing non-pharmacological and proactive pharmacological treatments for adults aged 19 to 69 with non-acute lumbar disc herniation who experience moderate or higher pain lasting more than one month. This randomized controlled study includes 200 patients from multiple hospitals, assigned equally to either treatment approach, to evaluate which strategy better manages the condition. The study is pragmatic, allowing treatments to be tailored by doctors without fixed protocols. Participants in the non-pharmacological group are recommended treatments like acupuncture, electroacupuncture, spinal manual therapy, and motion style acupuncture, typically twice weekly for eight weeks, with adjustments based on symptoms and clinical judgment. The pharmacological group receives active drug-related treatments such as prescription medications, injections, and nerve blocks on a similar schedule and with flexibility in dosing and frequency. Both groups may choose additional therapies, and all treatment details are recorded for comparison. During the 8-week treatment period and over a 3-year follow-up, participants undergo regular assessments including pain scores, disability indexes, quality of life surveys, and imaging evaluations. These measurements occur weekly during treatment and at multiple points throughout follow-up to monitor symptoms, recurrence, and overall treatment progress. The study tracks patient adherence, safety, and treatment impact to provide a comprehensive evaluation of both strategies.
CONDITIONS
Non-pharmacological Treatment vs Pharmacological Treatment for Non-acute Lumbar Disc Herniation
I
In-Hyuk Ha, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jaseng Medical Foundation
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 weeks
Participants receive either non-pharmacological treatments like acupuncture or pharmacological treatments such as medications or injections, typically twice a week for eight weeks. Treatments are adjusted based on clinical judgment.
Twice weekly visits
Duration - 3 years
Participants are monitored with regular assessments of pain, disability, and other outcomes over a 3-year period to track long-term treatment effects and recurrence.
Periodic visits at specified weeks and months
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Doori Kim, Yoon Jae Lee, Changsop Yang...
https://pubmed.ncbi.nlm.nih.gov/41477591/Jaseng Medical Foundation
Lead Sponsor